Daily market commentary. Investing is hard. That’s why it can be rewarding. TheStreetPro • SharkInvesting • Michigan Law & Business.
North Carolina
Joined June 2012
- Tweets108K
- Following1.4K
- Followers31.7K
- Likes11.9K
Pinned Tweet
Big Tech Is About to Report. My Plan: Do Nothing
Reports loom for Microsoft, Alphabet and Amazon, but I see no edge in trying to bet on those outcomes. Here’s what I’ll do instead. pro.thestreet.com/market-com…
AI adoption is NOT positively correlated with increased unemployment.
Faster AI adoption isn't leading to higher unemployment, per @RenMacLLC .
"If AI were costing jobs, the states where adoption rose most since November should be seeing jobless rates climb. They aren't. Across 46 states and DC, the correlation between the rise in AI use and the change in unemployment is -0.10, essentially nothing. For now, there's no sign that AI is pushing up unemployment where it's spreading fastest."
$ZURA Wedbush would be an aggressive buyer while Zura Bio remains below $4/share. The firm sees favorable risk/reward on the Q4 TibuSHIELD readout due to downside protection at about $3/share based on a cash position of $1.50/share plus a $2/share valuation in systemic sclerosis. Wedbush believes results are possible in November, based on the trial exceeding its enrollment targets as of June 26. The firm anticipates upside above $20/share should tibulizumab yield efficacy above an apparent limit for monotherapies in hidradenitis suppurativa. Wedbush rates the shares an Outperform, with a price target of $22.
The Story of the Market Is Access to Capital, Not Its Cost
Anthropic needs Broadcom guarantees to obtain massive loans. pro.thestreet.com/market-com…
James DePorre retweeted
In free nations, we investigate crimes to see who is guilty of them.
In communist tyrannies, they investigate men to see what they can be punished for.
$META Platforms 40M share Secondary priced at $625.00. The deal size increased from $22.5B to $25B. Morgan Stanley and Goldman Sachs served as joint book-running managers for the offering.
AI Sees Weak Bounce While Anthropic Filing Fails to Resolve Concerns
Chips and the mega caps bounced, but breadth was weak and new lows stayed high. pro.thestreet.com/market-com…
James DePorre retweeted
Great comment in the article about how sentiment is a position and those betting against $SPCX provide a built-in bid. Thanks Rev!
Love Musk or Hate Him, Here’s How I’m Building My SpaceX Position
Anthropic just filed a key financial doc, SpaceX reported earnings, and some investors are betting against Elon. Here’s what all that means for my position. $SPCX
pro.thestreet.com/trade-idea…
James DePorre retweeted
It was a tough week for investors and traders. Here is my best advice for getting back on track.
pro.thestreet.com/market-com…
My Stock of the Week for Oct 26 is live and features a name that has pulled back to key support amid broader AI pressure despite posting a strong quarter.
Read more: 👇
sharkinvesting.com/stock-of-…
$ANT | ANTHROPIC June 20 six-month revenue of $16.3 billion. Net loss of $80.7 billion for the same six-month period.
Neocloud Shakeout Sets Tone for Pivotal Week
With the Fed, Microsoft, Alphabet, and Amazon on deck, the debate over AI-related spending comes to a head. pro.thestreet.com/market-com…
